نتائج البحث

Renal Safety of Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Patients: An Evidence-based Case Report.

• Authors : Sandi Lesmana Dewi, Putu Itta¹; Narapati Pamungkas, Kadek Mercu¹; Mariadi, I. Ketut²

Subjects: *CHRONIC hepatitis B; *HEPATITIS B virus; *TENOFOVIR

• Source: Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy. Aug2024, Vol. 25 Issue 2, p271-277. 7p.

تفاصيل العنوان

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B.

• Authors : Cao, Fei¹ (AUTHOR); Fan, Tao¹ (AUTHOR); Jiang, Xue² (AUTHOR)

Subjects: *CHRONIC hepatitis B; *PROPENSITY score matching; *BLOOD lipids

• Source: Virology Journal. 9/28/2024, Vol. 21 Issue 1, p1-10. 10p.

تفاصيل العنوان

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

• Authors : Merchant, Elisabeth^1,2 (AUTHOR) ; Solleveld, Patricia³ (AUTHOR); Gibas, Kevin^4,5 (AUTHOR)

Subjects: *MEDICAL personnel; *PRE-exposure prophylaxis; *EMTRICITABINE-tenofovir

• Source: PLoS ONE. 12/5/2024, Vol. 19 Issue 12, p1-14. 14p.

تفاصيل العنوان

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate.

• Authors : Lin, Shenglong¹ (AUTHOR); Huang, Wanlong^1,2 (AUTHOR); Liao, Ziyuan¹ (AUTHOR)

Subjects: *CHRONIC hepatitis B; *BLOOD lipids; *PROPENSITY score matching

• Source: Scientific Reports. 11/9/2024, p1-11. 11p.

تفاصيل العنوان

富马酸丙酚替诺福韦治疗首次失代偿期乙型肝炎肝硬化患者的 效果和安全性分析.

• Authors : 荣, 欣欣¹ (AUTHOR); 徐, 缘媛¹ (AUTHOR); 杨, 广德¹ (AUTHOR)

• Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Oct2024, Vol. 40 Issue 10, p2008-2013. 6p.

تفاصيل العنوان

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis.

• Authors : Yoo, Jeong‐Ju¹ (AUTHOR); Jung, Eun Ae² (AUTHOR); Kim, Sang Gyune¹ (AUTHOR)

Subjects: *HIV-positive persons; *BODY mass index; *ANTIRETROVIRAL agents

• Source: Journal of the International AIDS Society. Sep2024, Vol. 27 Issue 9, p1-18. 18p.

تفاصيل العنوان

紫叶丹胶囊与富马酸丙酚替诺福韦片联合治疗对慢性乙型肝炎患者 肝功能、肝纤维化和血清 M-CSF、CTGF、CHI3L1 的影响.

• Authors : 蒋雨桐¹ ; 谢学建¹; 王 燕¹

Subjects: *CONNECTIVE tissue growth factor; *HEPATIC fibrosis; *MACROPHAGE colony-stimulating factor

• Source: Progress in Modern Biomedicine. Nov2024, Vol. 24 Issue 22, p4311-4313. 3p.

تفاصيل العنوان

Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.

• Authors : Zeng, Qing-Lei¹ (AUTHOR) ; Chen, Ru-Yue¹ (AUTHOR); Lv, Xue-Yan¹ (AUTHOR)

Subjects: *HEPATITIS associated antigen; *GROWTH disorders; *ALANINE aminotransferase

• Source: BMC Infectious Diseases. 8/15/2024, Vol. 24 Issue 1, p1-11. 11p.

تفاصيل العنوان

Short-Term Efficacy of Tenofovir Alafenamide in Acute-On-Chronic Liver Failure: A Single Center Experience.

• Authors : Li, Zhiqin¹ (AUTHOR) ; Zhu, Ruirui¹ (AUTHOR); Dong, Jianxia¹ (AUTHOR)

Subjects: *PATIENT safety; *VIROLOGY; *RESEARCH funding

• Source: Clinical Pathology. 8/12/2024, p1-7. 7p.

تفاصيل العنوان

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

• Authors : Lee, Shu-Yuan¹ (AUTHOR); Lin, Yi-Chun¹ (AUTHOR); Chen, Cheng-Pin^1,2 (AUTHOR)

Subjects: *NUCLEOSIDE reverse transcriptase inhibitors; *NON-nucleoside reverse transcriptase inhibitors; *HIV

• Source: PLoS ONE. 11/20/2024, Vol. 19 Issue 11, p1-13. 13p.

تفاصيل العنوان